title: Treatment of Tourette syndrome.
abstract: Tourette's syndrome (TS) consists of chronic motor and phonic tics and characteristically begins in childhood. The tics can be disabling and commonly associated behavioral comorbities such as attention deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD), can also cause problems in daily functioning. The underlying etiology and neurobiology of TS remain unknown although genetic factors appear to be important, cortical control of basal ganglia motor function appears to be disturbed and neurochemical abnormalities, particularly involving dopamine neurotransmission, are likely present. The treatment of TS involves appropriate education and support. Tics can be treated with habit reversal cognitive behavioral therapy, medications (most commonly alpha agonists and antipsychotics), local intramuscular injections of botulinum toxin and some severe, refractory cases have responded to deep brain stimulation surgery (DBS). It is important to appropriately diagnose and treat comorbid behavioral disorders that are disrupting function. OCD can be treated with cognitive behavioral therapy, selective serotonin reuptake inhibitors, and atypical antipsychotics. DBS has become a treatment option for patients with disabling OCD despite other therapies. ADHD is treated with appropriate classroom accommodations, behavioral therapy, alpha agonists, atomoxetine or methylphenidate-containing stimulant drugs.
authors.affiliation: Movement Disorders Program, Atlantic Neuroscience Institute, Overlook Medical Center, 99 Beauvoir Avenue, Summit, NJ, 07902, USA, roger.kurlan@atlantichealth.org.
authors.forename: Roger M
authors.initials: RM
authors.lastname: Kurlan
mesh_terms: D046690:Deep Brain Stimulation / Q000379:methods*; D006801:Humans; D005879:Tourette Syndrome / Q000628:therapy*
references.citation: Am J Psychiatry. 2001 Jul;158(7):1067-74
references.pmid: 11431228
references.citation: Neurology. 2003 Apr 8;60(7):1130-5
references.pmid: 12682319
references.citation: Mov Disord. 2007 Sep 15;22(12):1743-50
references.pmid: 17566119
references.citation: JAMA. 2010 May 19;303(19):1929-37
references.pmid: 20483969
references.citation: Arch Gen Psychiatry. 1991 Apr;48(4):324-8
references.pmid: 2009034
references.citation: Biol Psychiatry. 2008 Aug 1;64(3):248-51
references.pmid: 18243162
references.citation: Mov Disord. 2011 Nov;26(13):2442-3
references.pmid: 21956454
references.citation: Mov Disord. 2012 May;27(6):775-8
references.pmid: 22407510
references.citation: Stereotact Funct Neurosurg. 2012;90(4):213-24
references.pmid: 22699684
references.citation: Neurology. 1999 Mar 10;52(4):874-7
references.pmid: 10078748
references.citation: Neurology. 2008 May 6;70(19):1699-706
references.pmid: 18458230
references.citation: Mov Disord. 2011 May;26(6):1149-56
references.pmid: 21484868
references.citation: Behav Neurol. 2013;27(1):65-73
references.pmid: 23187151
references.citation: NeuroRx. 2006 Apr;3(2):192-206
references.pmid: 16554257
references.citation: Neuroscientist. 2013 Feb;19(1):101-8
references.pmid: 22596263
references.citation: Clin Drug Investig. 2008;28(7):443-59
references.pmid: 18544005
references.citation: Mov Disord. 2011 Jan;26(1):147-52
references.pmid: 20818603
references.citation: Eur Child Adolesc Psychiatry. 2011 Apr;20(4):173-96
references.pmid: 21445724
references.citation: Neurology. 2005 Dec 27;65(12):1941-9
references.pmid: 16380617
references.citation: J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):70-3
references.pmid: 19726418
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):840-8
references.pmid: 17581448
references.citation: J Neurosurg. 2007 Nov;107(5):1004-14
references.pmid: 17977274
references.citation: J Comp Neurol. 2010 Feb 1;518(3):277-91
references.pmid: 19941350
references.citation: Brain. 2012 Jun;135(Pt 6):1926-36
references.pmid: 22577221
references.citation: J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):136-42
references.pmid: 17846115
references.citation: J Clin Psychopharmacol. 2002 Feb;22(1):31-9
references.pmid: 11799340
references.citation: Arch Neurol. 2000 Aug;57(8):1190-3
references.pmid: 10927800
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13307-12
references.pmid: 16131542